Mereo BioPharma Group plc Analytics - Traffic, Statistics and Competitor Tracking


Mereo BioPharma Group plc Website Screenshot

http://www.mereobiopharma.com

Mereo BioPharma Group plc Company Intro

Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company also develops Navicixizumab (OMP-305B83) that is in Phase 1a clinical trial for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that has completed Phase II clinical trial to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody, which is in Phase IIb clinical trial for the treatment of osteogenesis imperfect; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. Mereo BioPharma Group plc was founded in 2015 and is based in London, the United Kingdom.

Industry

Healthcare

Mereo BioPharma Group plc Headquaters

1 Cavendish Place
London,W1G 0QF
United Kingdom


Mereo BioPharma Group plc Share price

07 May 2021 02:13 GMT

$0

0.0 (0 %)


Mereo BioPharma Group plc Market cap

$


WMC RANKING

2021

Mereo BioPharma Group plc # 442

Biotechnology

Latest Mereo BioPharma Group plc News



WMC Market Score


WMC Market to Revenue Score


Mereo BioPharma Group plc Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Mereo BioPharma Group plc GBP £0 £15,909 £-34,844 £ 442
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $531,210B 1
Vertex Pharmaceuticals Incorporated USD $6,205,683 $2,599,993 $2,711,647 $556,170B 2
Alexion Pharmaceuticals, Inc. USD $6,069,900 $2,656,500 $603,400 $375,420B 3
Incyte Corporation USD $2,229,409 $1,622,822 $446,906 $180,980B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Mereo BioPharma Group plc Social Followers vs Top 4 Industry Competitors



Mereo BioPharma Group plc Post vs Top 4 Industry Competitors




Mereo BioPharma Group plc Digital Footprint By Size vs Top 4 Industry Competitors



Mereo BioPharma Group plc Digital Footprint By Change Rate vs Top 4 Industry Competitors



Mereo BioPharma Group plc WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Mereo BioPharma Group plc 0 0 0 0 0 0 0.07
Regeneron Pharmaceuticals, Inc. 100 23.94 3.18 100 0 0 48.88
Vertex Pharmaceuticals Incorporated 67.14 35.00 1.01 86 0 0 46.84
Alexion Pharmaceuticals, Inc. 65.67 100 100 60 0 0 100
Incyte Corporation 24.12 4.94 0.07 2 0 0 2.86

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries